Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0002081460-26-000002

SVP, General Counsel sold 4,745 shares at $16.35 ($77,581)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cho Esther SVP, General Counsel 2026-02-18 Sale −4,745 $16.35 $77,581 39,755 D
Open-market sales · 4,745 sh · avg $16.35 · $77,581
Loading xslF345X05/form4-02202026_040204.xml…